Home/Fulgent Genetics/Brandon Perthuis
BP

Brandon Perthuis

Chief Commercial Officer (CCO)

Fulgent Genetics

Fulgent Genetics Pipeline

DrugIndicationPhase
Nanoencapsulation & Targeted Therapy PlatformBroad range of cancersPre-clinical